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Voltage-gated sodium channel function from neonatal and adult rat cardiomyocytes was measured and compared. 
Channels from neonatal ventricles required an  10 mV greater depolarization for voltage-dependent gating events 
than did channels from neonatal atria and adult atria and ventricles. We questioned whether such gating shifts 
were due to developmental and/or chamber-dependent changes in channel-associated functional sialic acids. 
Thus, all gating characteristics for channels from neonatal atria and adult atria and ventricles shifted signifi  cantly 
to more depolarized potentials after removal of surface sialic acids. Desialylation of channels from neonatal ventri-
cles did not affect channel gating. After removal of the complete surface N-glycosylation structures, gating of chan-
nels from neonatal atria and adult atria and ventricles shifted to depolarized potentials nearly identical to those 
measured for channels from neonatal ventricles. Gating of channels from neonatal ventricles were unaffected by 
such deglycosylation. Immunoblot gel shift analyses indicated that voltage-gated sodium channel α subunits from 
neonatal atria and adult atria and ventricles are more heavily sialylated than α subunits from neonatal ventricles. 
The data are consistent with approximately 15 more sialic acid residues attached to each α subunit from neonatal 
atria and adult atria and ventricles. The data indicate that differential sialylation of myocyte voltage-gated sodium 
channel α subunits is responsible for much of the developmental and chamber-specifi  c remodeling of channel gat-
ing observed here. Further, cardiac excitability is likely impacted by these sialic acid–dependent gating effects, such 
as modulation of the rate of recovery from inactivation. A novel mechanism is described by which cardiac voltage-
gated sodium channel gating and subsequently cardiac rhythms are modulated by changes in channel-associated 
sialic acids.
Correspondence to Eric Bennett: esbennet@hsc.usf.edu Correspondence to Eric Bennett: esbennet@hsc.usf.edu
INTRODUCTION
Voltage-gated sodium channels, Nav, are responsible for 
the initiation and propagation of action potentials in 
excitable tissues, opening rapidly and then inactivating 
after a membrane depolarization (Hille, 2001). The or-
chestrated activation and inactivation of Nav is vital to 
normal skeletal muscle and neuronal function, and in 
maintaining normal heart rhythm. Slight changes in 
channel function may cause myotonia, paralysis, epi-
lepsy, long QT syndrome (LQTS), idiopathic ventricu-
lar fi   brillation (IVF), heart failure, or other cardiac 
conduction disorders (Bennett et al., 1995; Wang et al., 
1995; Keating and Sanguinetti, 1996; Priori et al., 1999; 
Chen et al., 1998; Green et al., 1998; Bendahhou et al., 
1999; Makita et al., 2000; Wehrens et al., 2000; Abriel 
et al., 2001; Nuyens et al., 2001; Ufret-Vincenty et al., 
2001a; Wallace et al., 2001; Splawski et al., 2002; Spam-
panato et al., 2004).
To date, reports indicate that several α subunit iso-
forms are expressed variably throughout the heart, includ-
ing, Nav1.1, Nav1.3, Nav1.4, Nav1.5, and Nav1.6 (Rogart et al., 
1989; Dhar Malhotra et al., 2001; Maier et al., 2002, 2004; 
Haufe et al., 2005). However, data indicate that Nav1.5 is 
the major current-carrying α subunit expressed in the 
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sarcolemma (Maier et al., 2002; Zimmer and Benndorf, 
2002; Haufe et al., 2005). Thus, apparently, Nav1.5 is pri-
marily responsible for the initiation and propagation of 
action potentials resulting in ventricular systole.
Nav are typically heavily glycosylated with up to 35% 
of their total mass attributed to carbohydrate (Messner 
and Catterall, 1985; Roberts and Barchi, 1987; Schmidt 
and Catterall, 1987; Gordon et al., 1988; Cohen and 
Levitt, 1993). A large percentage of these sugars are 
  sialic acid (SA) residues (Roberts and Barchi, 1987). 
Reports have indicated that SA, which is negatively 
charged at physiological pH, may play a role in channel 
function. Nearly identical depolarizing shifts in Nav1.4 
gating were observed using three independent methods 
to reduce channel sialylation (Bennett et al., 1997).
Another study showed that sialic acid directly altered 
Nav gating in an isoform-specifi   c manner (Bennett, 
2002). All measured Nav1.4 gating parameters were 
shifted by a depolarizing 11–15 mV when Nav1.4 was 
  undersialylated, while sialic acid had no signifi  cant ef-
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through converse chimeric analysis in which the Nav1.4 
IS5-S6 loop was replaced by the analogous Nav1.5 loop 
(hSkM1P1) and vice versa (hH1P1). Gating phenotypes 
were switched, with hSkM1P1 gating independently 
of sialic acid, while hH1P1 gating was generally sialic 
acid dependent. These experiments provided two novel 
fi  ndings: (1) removal/creation of sialic acid sensitivity 
to Nav1.4/Nav1.5, respectively, verifi  es that for this system, 
Nav1.4 is sialic acid sensitive while Nav1.5 is insensitive; 
and (2) functional sialic acids in this system are local-
ized to the Nav1.4 IS5-S6 loop. Thus, sialic acids attached 
to the Nav1.4 IS5-S6 loop are necessary and suffi  cient to 
impose a uniform electrostatic effect on channel gat-
ing, while Nav1.5 sialic acids had no measurable effect on 
channel gating. While sialic acids in this system appar-
ently worked through an electrostatic mechanism, sialic 
acids might impose electrostatic and structural effects 
on channel gating, as previously suggested for Kv1.1 
(Watanabe et al., 2003).
Interestingly, while previous data indicated that SA 
had no impact on Nav1.5 gating as expressed in Chinese 
hamster ovary (CHO) cells, chemical desialylation of 
Nav1.5 expressed in HEK 293 cells resulted in depolar-
izing shifts in Va (Zhang et al., 1999; Bennett, 2002). 
  Because the effects of sialic acid on channel gating vary 
with the expression system used, studies of Nav function 
in cardiomyocytes would most directly address whether 
sialic acid alters cardiac Nav gating.
Previous studies have suggested that channel glycosyl-
ation may impact heart function. Desialylation via neur-
aminidase treatment increased L and T-type Ca2+ 
currents in rabbit sino-atrial nodal cells and ventricular 
myocytes (Fermini and Nathan, 1991; Marengo et al., 
1998). Neuraminidase treatment of adult mouse ven-
tricular myocytes altered the voltage dependence and 
conductance of transient outward K+ and fast inward 
Na+ currents and reduced the number of rat cardiac M2 
muscarinic agonist–receptor complexes (Haddad et al., 
1990; Ufret-Vincenty et al., 2001a,b).
Here we examined the differences in Nav gating be-
tween neonatal and adult cardiomyocytes from atria and 
ventricles under conditions of full and reduced sialylation 
and N-glycosylation. We fi  nd that the majority of differ-
ences in Nav gating between neonatal heart chambers 
and throughout the developing ventricle can be ac-
counted for by differential glycosylation, with changes in 
functional sialylation the most dominant effect. A model 
by which this differential sialylation might alter cardiac 
excitability most notably through signifi  cant modulation 
of Nav recovery from inactivation is proposed.
MATERIALS AND METHODS
Cardiac Myocyte Isolation and Culture
Myocytes were isolated from male neonatal (3–5 d) and adult 
(10–12 wk) Sprague-Dawley rats. The neonatal myocyte isola-
tion protocol was adapted from a method previously described 
(  Isenberg and Klockner, 1982). In detail, neonatal rats were an-
aesthetized with pentobarbital sodium (200 mg/kg). Atrial or ven-
tricular tissue was dissected out and washed in Ca2+-free   Tyrodes 
solution and then separated into individual myocytes by immer-
sion in 0.1% collagenase (Sigma-Aldrich type I) solution for 0.5 h, 
centrifuged for 5 min at 160 g, and then retreated with fresh colla-
genase solution for 1 h. Tissue was triturated to disperse myocytes. 
The myocyte-rich collagenase solution was centrifuged, rinsed with 
Krebs–HEPES bicarbonate solution, centrifuged again, and then 
plated with culture media. Adult ventricular and atrial  myocytes were 
isolated using a Langendorf perfusion protocol (7–10 ml/min) 
adapted from a method previously described (Saint et al., 1992). Adult 
rats were anaesthetized with pentobarbital sodium (200 mg/kg) 
and hearts were then dissected out. Whole hearts were fi  rst per-
fused with Ca2+-free Tyrodes for 5 min, then with 300 U/ml 
collagenase (Sigma-Aldrich type I) and 280 μg/ml protease 
(Sigma-Aldrich type XIV) in Ca2+-free Tyrodes for 12 min, fol-
lowed by 5 min of 0.1 mmol/liter Ca2+ Tyrodes. Atrial/ventric-
ular tissue was then removed and triturated in 0.1 mmol/liter 
Ca2+ Tyrodes, run through a 200 μm fi  lter, rinsed three times 
with culture media, and then plated. Cells were used for electro-
physiological experiments within 72 h of plating. All chemicals, 
reagents, enzymes, and animal tissue were stored, used, and dis-
posed of following guidelines outlined in product literature, and 
established and approved by the USF Institutional Animal Care 
and Use Committee (IACUC).
Whole-cell Recording of Rat Cardiomyocyte Sodium Currents
Cardiomyocytes were studied using the patch-clamp whole-cell 
recording technique previously described (Bennett et al., 1997). 
Experiments were done using an Axon Instruments 200B patch-
clamp amplifi  er with a CV203BU headstage (Axon Instruments) 
used in combination with a Nikon TE200 inverted microscope. 
The pulse protocols were generated using a Pentium II computer 
(Dell Computers) running pulse acquisition software (HEKA). 
The resulting analogue signals were fi   ltered at 5 kHz using 
an eight-pole Bessel fi  lter (9200 LPF; Frequency Devices) and 
then digitized using the ITC-16 AD/DA converter (Instrutech).   
A micromanipulator (MP-285 Sutter) was used to place the 
  electrode on the cell. Electrode glass (Drummond capillary tubes) 
was pulled using a Sutter (model P-87) electrode puller to resis-
tances of 1–2 MΩ.
Whole-cell recording extracellular solution was (in mmol/ 
liter) 5 NaCl, 10 tetraethylsulfamide (TES), 5 KCl, 1 CaCl2, 5 CsCl, 
10 glucose, 115 choline chloride. The electrode solution was (in 
mmol/liter) 120 CsF, 10 TES, 2 MgCl2, 2 CaCl2, 5 NaCl, 20 EGTA. 
Using these salt solutions, similar average current densities were 
measured for each cell type. No current densities were impacted 
signifi  cantly by neuraminidase treatment, consistent with our pre-
vious work that suggested channel conductance is not signifi  cantly 
affected by desialylation (Bennett et al., 1997).
To ensure proper space clamping of the myocyte, several 
measures were taken. (1) Data were analyzed from cells pro-
ducing sodium currents of 7 nA or less and reversing near the 
predicted sodium reversal potential. This required using solu-
tions that contained only 5 mM NaCl. (2) Only myocytes of 
76 pF or less were analyzed to ensure space clamp fi  delity. (3) The 
slopes of the G-V Boltzmann relationships were monitored, and 
only cells in which the slope was >5 mV were analyzed. Any 
steeper slope indicated a loss of voltage clamp. (4) All analyzed 
data were collected between 8–12 min after achieving whole-
cell confi  guration.
In addition, all data were series resistance compensated to 
95–98%. If proper compensation was not achieved, the data 
were not analyzed. All experiments were performed at room 
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Desialylation/Deglycosylation of Cardiomyocytes
To remove sialic acids, cells were plated onto 35-mm dishes and ex-
posed to 1.125–1.5 U neuraminidase (Sigma-Aldrich type X)/ml 
Dulbecco’s modifi  ed Eagle’s medium for 3 h at 37°C. To remove 
N-glycosylation, cells were exposed to 19–20 U PNGase-F (Sigma-
Aldrich)/ml Dulbecco’s modifi  ed Eagle’s medium for 12 h at 
37°C. Each glycosidase is relatively specifi  c. The neuraminidase 
will break α2-3, α2-6, and, to a lesser extent, α2-8 linkages of sialic 
acids attached to carbohydrate structures. PNGase-F is very spe-
cifi  c for breaking the linkage between N-acetylglucosamine and 
the asparagine residue to which it is attached.
Pulse Protocols
Conductance–Voltage (G-V) Relationship. Pulse protocols were 
performed as previously described using a −120 mV holding po-
tential (Bennett, 2002). The cells were stepped for 10 ms from the 
holding potential to various depolarized potentials, ranging from 
−100 to +40 mV in 10-mV increments. Consecutive pulses were 
stepped every 1.5 s and the data were leak subtracted using the 
P/4 method, stepping negatively from the holding potential. 
At each test potential, steady-state whole-cell conductance was de-
termined by measuring the peak current at that potential and 
  dividing by the driving force (i.e., difference between the mem-
brane potential and the observed reversal potential). Peak con-
ductance as a function of membrane potential was plotted. The 
maximum sodium conductance for a single cell was determined 
following single Boltzmann fi  ts to the data (Eq. 1, solving for max-
imum conductance). The average Va ± SEM values listed in Table I 
are determined from these data fi  ts. As illustrated in Figs. 2 and 6, 
there are no obvious differences in the Ka ± glycosidase treat-
ment, and therefore Ka values are not listed in Table I. Statistical 
comparisons of Ka ± glycosidase treatment showed no signifi  cant 
differences (P < 0.02), and the measured Ka ± SEM for untreated, 
neuraminidase-treated, and PNGase-F treated, respectively, were 
(in mV): (1) neonatal atria: 8.6 ± 0.2, 8.9 ± 0.4, and 8.1 ± 0.6; 
(2) adult atria: 7.7 ± 0.3, 8.2 ± 0.3, and 8.2 ± 0.6; (3) neonatal 
ventricle: 9.2 ± 0.5, 9.0 ± 0.3, and 8.0 ± 0.4; and (4) adult ventri-
cle: 7.0 ± 0.4, 6.0 ± 0.3, and 7.4 ± 0.3.
From the Boltzmann fi  ts, the normalized data were then aver-
aged with those from other cells, and the resultant average 
  conductance–voltage curve was determined using the following 
Boltzmann relation fi  t to the data:
(1)
() ()
1
aa Fraction of maximal conductance    1    exp  V   V K , ⎡⎤ ⎣⎦
 
       
where V is the membrane potential, Va is the voltage of half activa-
tion, and Ka is the slope factor.
Steady-state Inactivation Curves (hinf). Cells were fi  rst prepulsed 
for 500 ms from the holding potential to the plotted potentials 
ranging from −130 to −20 mV in 10-mV increments, then to a 
+40 mV test pulse for 5 ms. Currents from each cell were nor-
malized to the maximum current measured by single Boltzmann 
fi  ts to the data from a single cell (Eq. 2, solving for maximum 
current), from which the mean Vi ± SEM values listed in Table I 
were determined. As illustrated in Figs. 3 and 6, there are no ob-
vious differences in the Ki ± glycosidase treatment, and there-
fore Ki values are not listed in   Table I. Statistical comparisons of 
Ki ± glycosidase treatment showed no signifi  cant differences (P < 
0.02), and the measured Ki ± SEM for untreated, neuraminidase-
treated, and PNGase-F treated, res  pectively, were (in mV): (1) 
neonatal atria: −7.2 ± 0.2, −7.8 ± 0.2, and −7.9 ± 0.6; (2) adult 
atria: −7.2 ± 0.2, −7.8 ± 0.2, and −8.0 ± 0.4; (3) neonatal ventri-
cle: −7.9 ± 0.2, −7.8 ± 0.4, and −8.6 ± 0.5; and (4) adult ventricle: 
−7.8 ± 0.3, −8.1 ± 0.3, and −7.1 ± 0.4.
TABLE I
Gating Parameters for Nav from Neonatal and Adult Cardiomyocytes under Conditions of Full and Reduced Sialylation/Glycosylation
Myocyte type Treatment n Va Vi τh at −50 mV τrec at −120 mV
mV mV ms ms
Neonatal ventricle Control/Untreated 11 −46.1 ± 1.0 −87.8 ± 1.5 4.0 ± 0.2 7.9 ± 0.3
Neuraminidase 11 −46.8 ± 1.0a −88.7 ± 1.2a 4.9 ± 0.4a 7.9 ± 0.6a
PNGase-F 6 −49.5 ± 1.5a −90.6 ± 1.1a 3.6 ± 0.3a 8.4 ± 0.6a
Adult ventricle Control/Untreated 8 −56.9 ± 1.1c −97.1 ± 2.7c 2.8 ± 0.1c 13.7 ± 1.9c
Neuraminidase 8
Uc; Na
−47.3 ± 1.6
Uc; Na
−83.8 ± 2.1
Uc; Na
4.7 ± 0.7
Uc; Nc
5.4 ± 0.7
PNGase-F 7
Uc; Na
−48.3 ± 2.0
Uc; Na
−86.7 ± 2.6
Uc; Na
3.7 ± 0.5
Uc; Na
7.6 ± 0.7
Neonatal atrium Control/Untreated 17 −57.0 ± 0.6c −100.0 ± 0.7c 2.2 ± 0.1c 18.1 ± 1.2c
Neuraminidase 13
Uc; Na
−49.9 ± 1.1
Ub; Nc
−95.4 ± 1.8
Uc; Nc
3.2 ± 0.2
Uc; Nc
13.2 ± 1.7
PNGase-F 6
Uc; Na
−47.2 ± 2.0
Uc; Na
−86.3 ± 2.0
Uc; Na
4.5 ± 0.6
Uc; Na
8.0 ± 0.9
Adult atrium Control/Untreated 13 −56.7 ± 1.0c −96.7 ± 1.5c 2.0 ± 0.1c 14.5 ± 1.5c
Neuraminidase 11
Uc; Na
−49.9 ± 1.0
Uc; Na
−91.3 ± 0.9
Uc; Nc
3.3 ± 0.2
Uc; Na
9.7 ± 0.8
PNGase-F 7
Uc; Na
−50.0 ± 1.0
Uc; Na
−88.8 ± 1.9
Uc; Na
3.0 ± 0.3
Uc; Na
9.9 ± 1.2
The mean gating parameter values ± SEM are listed. Va, voltage of half-activation; Vi, Voltage of half-inactivation; τh, fast inactivation time constant; 
τrec, time constant for recovery from fast inactivation. Signifi  cance was determined using a two-tailed Student’s t test comparing sample groups as follows: 
(1) untreated samples were compared to untreated neonatal ventricular myocytes, (2) treated samples were compared to their untreated cell type (U), and 
neonatal ventricular myocytes (N).
aNot signifi  cant.
bSignifi  cant (P < 0.02).
cHighly signifi  cant (P < 0.01).256 Sialylation Modulates Cardiac Na+ Channel Gating
From the Boltzmann fi  ts, the normalized data for many cells were 
then averaged and the following Eq. 2 was fi  t to these data to produce 
the least squares fi  t curves shown in Fig. 1 B, Fig. 3, and Fig. 6 B:
(2)
() () ()
1
ii Fraction of maximum current    1    exp V   V K , ⎡⎤
⎣⎦
 
    
where V is the membrane potential, Vi is the voltage of half inacti-
vation, and Ki is the slope factor.
Measurement of Inactivation Time Constants (τh). Inactivation 
time constants were determined by fi  tting to single exponential 
functions the attenuating portions of the current traces used to 
measure the G-V relationships.
Recovery from Inactivation. Cells were held at −120 mV, pulsed to 
+40 mV for 10 ms, and then stepped to the recovery potential for 
1–20 ms in 1-ms increments. After the recovery pulse, the potential 
was again stepped to +40 mV for 10 ms. The peak currents  measured 
during the two +40 mV depolarizations were compared to deter-
mine the fractional current (recovery) measured during the second 
pulse. The fractional current was plotted as a function of the recovery 
time (in ms) between the two test pulses to +40 mV (Fig. 1 D, inset, 
labeled as I/Io). Single exponential functions were fi  t to the data to 
determine the time constants for recovery from fast inactivation, τrec.
Immunoblot
Cellular homogenates were made by fi  rst harvesting the appropri-
ate tissues (neonatal and adult cardiac atrial/ventricular muscle). 
The tissue was placed in ice cold sodium pyrophosphate buffer 
containing protease inhibitors (20 mmol/liter tetrasodium pyro-
phosphate, 20 mmol/liter Na2PO4, 1 mmol/liter MgCl2, 0.5 mmol/
liter EDTA, 300 mmol/liter sucrose, 0.8 mmol/liter benzamidine, 
1 mmol/liter iodacetamide, 1.1 μmol/liter leupeptin, 0.7 μM 
pepstatin, 76.8 nM aprotinin), and homogenized using a Polytron 
homogenizer (Brinkmann Instruments model PT10/35), set at 
10, pulsed several times to ensure complete homogenization, and 
then stored at −80°C. Samples were mixed with sample buffer 
(10% glycerol, 5% 2-mercaptoethanol, 3% SDS, 12.5% upper Tris 
buffer [upper Tris buffer is 500 mM Tris, 0.4% SDS, pH 6.8]), de-
natured for 2 min in boiled water, and then loaded into the lanes 
of a minigel cast from 4.5% acrylamide. The gel was run for its full 
length at 75–100 V and then electrophoretically transferred to ni-
trocellulose paper using a semi-dry transfer cell (Bio-Rad Labora-
tories) for 22 min at 8–14 V. Treated homogenates were incubated 
with 1.35 U neuraminidase/10 μg protein for 3 h at 37°C to remove 
sialic acids, and with 19–20 U PNGase-F (Sigma-Aldrich)/10 μg 
protein for 12 h at 37°C to remove N-glycosylation structures. 
  Cardiac sodium channel α subunits were detected using a 1:200 
dilution of a site-directed polyclonal pan-specifi  c antibody previ-
ously described (αAb) (Bennett, 1999), and then incubated with 
donkey anti-rabbit horseradish peroxidase–conjugated secondary 
antibody (Amersham Biosciences) for 2 h, and visualized using a 
Pierce Chemical Co. enhanced chemiluminescence kit.
Data Analysis
All electrophysiological data were analyzed using Pulse/PulseFit 
(HEKA) and Sigmaplot 2001 (SSPS Inc.) software. Sigmagel 
(SSPS Inc.) software was used to quantify the immunoblot data.
RESULTS
Nav from Neonatal Ventricles Gate at More 
Depolarized Potentials
Whole-cell Na+ currents similar to those shown in Fig. 
1 A were recorded from single neonatal and adult car-
diomyocytes from atria and ventricles to determine de-
velopmental and chamber-specifi  c differences in Nav 
gating. Biophysical analyses revealed that gating of Nav 
from neonatal atria and adult atria and ventricles oc-
curred after smaller depolarizations than did gating 
of Nav from neonatal ventricles (Fig. 1, A–D). Steady-
state channel activation (G-V; Fig. 1 A) and inactiva-
tion (hinf; Fig. 1 B) curves for Nav from neonatal atria 
and adult atria and ventricles were 9–10 mV more hy-
perpolarized than those measured for channels from 
neonatal ventricles (Fig. 1, A and B). The fast inactiva-
tion time constants (τh) measured for Nav from neo-
natal atria and adult atria and ventricles were smaller 
(faster) than τh for Nav from neonatal ventricles (Fig. 
1 C).The time to recovery from fast inactivation (τrec) 
is slower for Nav from neonatal atria and adult atria 
and ventricles than for Nav from neonatal ventricles 
(Fig. 1 D). Collectively, these data reveal a consistent 
chamber-specifi   c difference in neonatal Nav gating, 
and a hyperpolarization in Nav gating as the ventricle 
develops. The mean values ± SEM for all voltage-
dependent gating parameters measured in this report 
are listed in Table I.
Steady-state Gating of Nav from Neonatal Atria and Adult 
Atria and Ventricles Are Sensitive to Desialylation while 
Nav Gating in the Neonatal Ventricle Is Insensitive
Nav gating was studied under conditions of full and re-
duced sialylation to determine whether the observed 
chamber-specifi   c and developmental shifts in gating 
could be attributed to differences in functional channel 
sialylation. Fig. 2 shows G-V curves for Nav from each 
myocyte type ± SA (surface SA removed by treating 
with neuraminidase). Note that the G-V curves for Nav 
from neonatal atria and adult atria and ventricles treated 
with neuraminidase were shifted in the depolarized di-
rection by a signifi  cant 7–10 mV, while neuraminidase 
treatment had no effect on the G-V relationship for Nav 
from neonatal ventricles.
Desialylation similarly altered steady-state inactiva-
tion, with neuraminidase causing a signifi  cant 5–13 mV 
shift in hinf curves for channels from neonatal atria 
and adult atria and ventricles, with no effect on steady-
state inactivation of channels from neonatal ventricles 
(Fig. 3).
Sialic Acids Increase Inactivation Rate; Only τh for Nav 
from Neonatal Ventricles Is Insensitive to Sialic Acids
Fig. 4 shows that desialylation slowed the rate of fast 
  inactivation for Nav from neonatal atria and adult atria 
and ventricles (Fig. 4, A, B, and D) with little or no  effect 
on the τh measured for Nav from neonatal ventricles 
(Fig. 4 C). Note, similar to that observed for steady-state 
gating, desialylation shifted the τh curves toward τh mea-
sured for channels from neonatal ventricles (which are 
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Sialic Acids Slow the Rate of Recovery from Fast 
Inactivation for Nav from All Myocyte Types Except 
Neonatal Ventricles
Fully sialylated Nav from neonatal atria and adult atria 
and ventricles consistently recovered from inactivation 
more slowly than did Nav from neonatal ventricles 
(Fig. 1 A). After desialylation, Nav recovery time de-
creased for all but Nav from neonatal ventricles (Fig. 5), 
toward those values measured for Nav from neonatal 
ventricles (Table I).
Removal of N-glycosylation Can Account for Gating 
Differences among Nav Expressed throughout 
the Developing Myocardium
While the SA-induced shifts in gating observed can 
  account for the majority of differences in voltage-
  dependent Nav gating among myocyte types studied 
here, they do not fully account for these differences. 
One possible reason for this is that neuraminidase treat-
ment, while consistent in removing some functional SA 
from Nav, failed to remove all functional   sugars. To test 
this, we attempted to remove the complete N-  glycosylation 
structures from surface channels by treatment with 
PNGase-F. As shown in Fig. 6, PNGase-F treatment 
caused all gating characteristics for channels from neo-
natal atria and adult atria and ventricles to be nearly 
identical to those observed for Nav from neonatal ven-
tricles (which were SA and PNGase-F insensitive). In 
fact, after PNGase-F treatment, no signifi  cant  differ-
ences among myocyte types were observed for any Nav 
gating parameter (Table I).
The Nav α Subunits from Neonatal Atria and Adult Atria 
and Ventricles Are More Heavily Sialylated 
than the α Subunit from Neonatal Ventricles
Figs. 2–5 indicate that gating of Nav from neonatal atria 
and adult atria and ventricles are more sensitive to 
  desialylation than are Nav from neonatal ventricles. One 
possibility is that the Nav from neonatal ventricles is the 
least sialylated channel type, with changes in   channel 
Figure 1.  Nav from neonatal 
ventricles gate at more depolar-
ized potentials. Filled circles, 
neonatal ventricular myocytes 
(NV); open squares, adult ven-
tricular myocytes (AV); fi  lled 
triangles, neonatal atrial myo-
cytes (NA); open inverted tri-
angles, adult atrial myocytes 
(AA). The number of samples 
for each is listed in Table I. (A) 
Steady-state activation (G-V rela-
tionships). Data are the average 
normalized peak conductance ± 
SEM at a membrane potential. 
Curves are single Boltzmann dis-
tribution fi  ts to the data. Inset, 
whole cell Na+ current from an 
isolated adult ventricular myo-
cyte. Currents were measured 
during test pulses of −100 to 
+40 mV in 10-mV increments from 
the −120 mV holding potential. 
(B) Steady-state inactivation (hinf). 
Data are the average peak cur-
rent ± SEM measured during a 
5-ms pulse to +40 mV following 
a 500-ms prepulse to the plot-
ted potentials. Curves are single 
Boltzmann distribution fi  ts  to 
the data. Inset, whole cell Na+ 
currents  measured during a se-
ries of +40 mV test pulses, each 
following a prepulse to a larger 
depolarization ranging from −130 to −20mV in 10-mV increments. (C) Time constant of fast inactivation (τh). Data are the average 
τh ± SEM measured at the plotted potentials. Curves are nontheoretical point-to-point. Inset, current traces during a −50 mV test pulse. 
Solid traces, NA, AA, and AV. Dotted trace, NV. (D) Voltage dependence of the recovery time constants. Data are the measured time 
constants for recovery from inactivation (τrec) ± SEM as a function of recovery potential. Lines are nontheoretical point-to-point. Inset, 
plotted recovery data and fi  ts for all four conditions at a −130 mV recovery potential. Curves are single exponential function fi  ts to the 
data. Solid curves, NA, AA, and AV. Dotted curve, NV.258 Sialylation Modulates Cardiac Na+ Channel Gating
  sialylation levels occurring throughout the   developing 
ventricle and between the newborn’s   chambers. To test 
this possibility, multiple immunoblots were run to mea-
sure the apparent molecular weight (Mr) of Nav α subu-
nits expressed in the four myocyte types (Fig. 7). From 
these blots, it was apparent that the Nav α subunits from 
neonatal atria and adult atria and ventricles were simi-
lar in Mr, and were consistently more massive than the α 
subunit from neonatal ventricles (Fig. 7 A). The aver-
age measured Mr for α subunits from neonatal atria and 
adult atria and ventricles was 251.8 ± 0.6 kD (n = 41), 
versus 246.5 ± 0.8 kD (n = 19) for the α subunit from 
neo  natal ventricles. Thus, α subunits from neonatal 
atria and adult atria and ventricles were an average  5 kD 
larger than the α subunit from neonatal ventricles. 
  Because the α subunit Mr observed for all four homoge-
nates was signifi  cantly greater than the predicted Mr for 
unprocessed Nav1.5 ( 227 kD), the data indicate that all 
four α subunits are glycosylated, with the α subunit from 
neonatal ventricles being the least processed.
To determine more directly whether changes in chan-
nel glycosylation were responsible for the observed dif-
ferences in Mr, myocyte homogenates were treated with 
PNGase-F to remove N-linked glycosylation at the site of 
attachment to the channel. The Mr for all four PNGase-
F–treated  α subunits were reduced to an average 
231.1 ± 0.9 kD (n = 20), with no signifi  cant difference 
in Mr measured among the PNGase-F–treated α sub-
units (Fig. 7 B). These data indicate that the α subunit 
from neonatal ventricles is  5 kD less N-glycosylated 
than the other α subunits.
To question whether the differences in glycosyla-
tion levels observed were due to differences in α sub-
unit sialylation, myocyte homogenates were treated 
Figure 2.  Desialylation of Nav from neonatal atria and adult atria 
and ventricles causes a depolarizing shift in steady-state activa-
tion; only channels from neonatal ventricles are unaffected. 
G-V relationships for Nav ± neuraminidase. Data are the average 
normalized peak conductance ± SEM at a membrane potential. 
Curves are single Boltzmann distribution fi  ts to the data. Filled 
symbols, control/untreated. Open symbols, neuraminidase-
treated. Triangles, NA (A). Inverted Triangles, AA (B). Circles, 
NV (C). Squares, AV (D). The number of samples for each is 
listed in Table I.
Figure 3.  Desialylation shifts steady-state inactivation curves for 
Nav from neonatal atria and adult atria and ventricles but has 
no effect on inactivation of channels from neonatal ventricles. 
Steady-state inactivation (hinf) for Nav ± neuraminidase. Data are 
the average normalized peak current ± SEM measured during a 
5-ms test pulse to +40 mV after a 500-ms prepulse to the plotted 
potentials. Curves are single Boltzmann distribution fi  ts to the data. 
Filled symbols, control/untreated. Open symbols, neuraminidase-
treated. Triangles, NA (A). Inverted Triangles, AA (B). Circles, 
NV (C). Squares, AV (D). The number of samples for each is 
listed in Table I.
Figure 4.  Sialic acid increases the rate of fast inactivation for 
Nav from neonatal atria and adult atria and ventricles but has 
little   effect on τh for channels from neonatal ventricles. Time 
constants of fast inactivation (τh) ± neuraminidase. Data are the 
average  τh  ± SEM. Curves are nontheoretical, point-to-point. 
Filled symbols, control/untreated. Open symbols, neuraminidase-
treated. Triangles, NA (A). Inverted Triangles, AA (B).   Circles, 
NV (C). Squares, AV (D). The number of samples for each is 
listed in Table I.Stocker and Bennett 259
with neuraminidase to remove sialic acids specifi  cally 
(Fig. 7 C). The α subunit Mr for all homogenates 
were reduced to similar levels following neuramini-
dase treatment,   suggesting that all α subunits are si-
alylated, with the α subunits from neonatal atria and 
adult atria and ventricles being more sialylated than 
the α subunit from neonatal ventricles. Fig. 7 D illus-
trates the average α subunit Mr measured under con-
trol, PNGase-F, and neuraminidase-treated conditions 
(listed in Table II). The graph shows that the Mr for 
untreated α subunits from neonatal atria and adult 
atria and ventricles were nearly identical, while Mr for 
untreated α subunits from neonatal ventricles was sig-
nifi  cantly smaller. The Mr for each channel type was 
reduced to similar levels after treatment with each 
glycosidase. This indicates that a difference in channel 
sialylation is primarily responsible for the differences 
in α subunit Mr observed. On average, SA-dependent 
Mr (change in Mr with neuraminidase treatment) 
was  5.3 kD for the α subunit from neonatal ven-
tricles and a much larger 9.1 kD (72% increase) for 
the α subunits from each of the other myocyte types. 
In fact, direct comparison indicated a highly signifi  -
cant, 3.8 ± 0.4 kD larger SA-dependent shift in Mr 
(n = 23) for α subunits from neonatal atria and adult 
atria and ventricles than for α subunits from neonatal 
ventricles. This is consistent with  15 more sialic acid 
residues attached to the α subunits from neonatal 
atria and adult atria and ventricles than to α subunits 
from neonatal ventricles.
DISCUSSION
Remodeling of Nav Gating throughout the Developing 
Myocardium Is Dependent on Differential Nav Sialylation
Here, we observed that voltage-dependent steady-state 
and kinetic gating events for Nav from neonatal and 
adult atria and ventricles were shifted in the hyperpo-
larized direction by  10 mV compared with the gat-
ing characteristics  of  Nav from neonatal ventricles. 
We sought to explore what might be responsible for 
this Nav remodeling. We hypothesized that develop-
mental and/or chamber-dependent changes in chan-
nel-  associated functional sialic acids may account 
for some of these gating shifts. Neuraminidase treat-
ment was used to remove sialic acids attached to sur-
face Nav. None of the voltage-dependent gating 
characteristics for Nav from neonatal ventricles were 
affected by neuraminidase treatment, while all gating 
characteristics for Nav from neonatal atria and adult 
atria and ventricles were shifted to more depolarized 
potentials, toward those measured for Nav from neo-
natal ventricles.
Removal of N-linked sugars via PNGase-F treatment 
(Fig. 6) caused all gating characteristics for Nav from 
neonatal atria and adult atria and ventricles to behave 
nearly identically to those measured for channels from 
neonatal ventricles (control and glycosidase treated). 
There are likely inherent differences in Nav gating 
among myocyte types in addition to those described 
Figure 5.  Recovery from fast inactivation for Nav from neonatal 
atria and adult atria and ventricles is faster after desialylation; 
  recovery rates of channels from neonatal ventricles are unaffected 
by sialic acids. Voltage dependence of the time constants for re-
covery from inactivation ± neuraminidase. Data are the measured 
τrec ± SEM as a function of recovery potential. Lines are nontheo-
retical point-to-point. Filled symbols, control/untreated. Open 
symbols, neuraminidase treated. Triangles, NA (A). Inverted tri-
angles, AA (B). Circles, NV (C). Squares, AV (D). The number of 
samples for each is listed in Table I.
Figure 6.  Gating of deglycosylated Nav from neonatal atria and 
adult atria and ventricles is nearly identical to gating of channels 
from neonatal ventricles. Steady-state activation (A) and inacti-
vation (B) relationships and fast inactivation (C) and recovery 
(D) kinetics are shown for all channel types after treatment with 
PNGase-F (open symbols: triangles, NA; inverted triangles, AA; 
circles, NV; squares, AV), and for Nav from neonatal ventricles 
under control/untreated (solid circles) and neuraminidase-treated 
(dotted, open circles) conditions. Data are the mean ± SEM. 
Number of samples for each is listed in Table I.260 Sialylation Modulates Cardiac Na+ Channel Gating
here (e.g., effects of differential sympathetic input on 
Nav gating, see Zhang et al., 1992). However, our data, 
at a minimum, suggest that the majority of differences 
in Nav gating between neonatal heart chambers, and 
throughout the developing ventricle can be accounted 
for by differential glycosylation, with changes in func-
tional sialylation the most dominant effect. That is, 
functional SA, defi   ned here as the measurable SA-
  dependent effects on channel gating, account for the 
majority of differences in voltage-dependent gating of 
Nav among the myocyte types studied. Removal of the 
full N-glycosylation structures could account for all 
measured shifts in gating among Nav. It is possible that 
two distinct N-glycosylation–dependent mechanisms 
are responsible for the sugar-induced hyperpolarizing 
shifts in Nav gating. However, another likely possibility is 
that while neuraminidase treatment consistently re-
moved functional sialic acids, it may not have removed 
all functional sialic acids for each cell studied, while 
PNGase-F treatment was much more effective at remov-
ing functional sialic acids.
Previously, we showed that Nav1.5 gating can be af-
fected by trans sialic acids attached to the β1 subunit 
(Johnson et al., 2004). It is known that β1 expression 
increases with the developing ventricle. Our immuno-
blot data indicate a signifi  cant increase in β1 expres-
sion for adult ventricles compared with the adult atria 
and neonatal atria and ventricles (the adult atria and 
neonatal atria and ventricles expressed similar levels; 
unpublished data). We explored the possibility that β1 
sialic acids might be fully responsible for the shifts in 
gating for channels from adult ventricles. β1 overex-
pressed in neonatal ventricular myocytes had no effect 
on Nav steady-state activation or inactivation (n  = 4; 
data not shown), suggesting that simply adding β1 
to the α subunit is not suffi  cient to produce the SA- 
dependent hyperpolarization observed throughout the 
developing ventricle.
Immunoblot analyses indicated that Nav α subunits 
from neonatal atria and adult atria and ventricles were 
more heavily sialylated than α subunits from neonatal 
ventricles (Fig. 7). Gel shift studies predicted that  15 
fewer SA are attached to the α subunits from neonatal 
ventricles. While the immunoblot data indicate that the 
α subunits from neonatal ventricles are sialylated   (albeit 
signifi  cantly less sialylated), the sialic acids were not 
measurably functional. This is consistent with our previ-
ous study comparing effects of sialic acids on Nav1.4 and 
Nav1.5 gating in CHO cells (Bennett, 2002). We found 
that while Nav1.5 is apparently glycosylated as expressed 
in CHO cells, no functional effects of sugars on gating 
were observed. Evidently here, with a 72% increase in 
the num  ber of sialic acids attached to α subunits from 
neonatal atria and adult atria and ventricles, SA-
  dependent   function becomes measurable. Given this, 
the biochemical data are consistent with the biophysical 
measurements, suggesting that much of the differences 
in gating between Nav from neonatal ventricles and Nav 
from neonatal atria and adult atria and ventricles are 
the result of differential levels of functional sialylation. 
Figure 7.  Gel shift analyses indicate that α subunit sialylation in-
creases throughout the developing myocardium. Bands detected 
using αAb at a 1:200 concentration. Lane labels: NV, neonatal 
ventricle; AV, adult ventricle; NA, neonatal atria; AA, adult atria. 
(A) Immunoblot of Nav α subunits from neonatal and adult atria 
and ventricles. Lanes 1, 4, and 7, molecular weight markers; lane 2, 
NV; lane 3, AV; lane 5, NA; lane 6, AA. Protein loaded per lane: 
5 μg. (B) Immunoblot of Nav α subunits from neonatal and adult 
atria and ventricles ± PNGase-F treatment. Lanes 1, 6, and 11, 
molecular weight markers; lane 2, NV; lane 3, NV + PNGase-F; 
lane 4, AV + PNGase-F; lane 5, AV; lane 7, NA; lane 8, NA + 
PNGase-F; lane 9, AA + PNGase-F; lane 10, AA. Protein loaded 
per lane: control/untreated, 5 μg; PNGase-F-treated, 10 μg. 
(C) Immunoblot of Nav α subunits from neonatal and adult atria 
and ventricles ± neuraminidase treatment. Lanes 1, 6, and 11, 
molecular weight markers; lane 2, NV; lane 3, NV + neuramini-
dase; lane 4, AV + neuraminidase; lane 5, AV; lane 7, NA; lane 8, 
NA + neuraminidase; lane 9, AA + neuraminidase; lane 10, AA. 
Protein loaded per lane: control/untreated, 5 μg; neuraminidase 
treated, 10 μg. (D) Bar graph of average measured Nav α sub-
unit Mr ± PNGase-F ± neuraminidase. Each bar represents the 
mean Mr ± SEM measured for a series of immunoblots. Dark 
bars, untreated; light bars, PNGase-F treated; gray bars, neur-
aminidase treated. The number of samples measured is listed 
at the base of each bar. Signifi  cance was determined for the 
  untreated data using a two-tailed Student’s t test comparing the 
Mr for the α subunit from neonatal ventricles to the Mr for the α 
subunits from neonatal atria and adult atria and ventricles. 
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Apparently, the numbers/locations of functional sialic 
acids added to Nav are regulated as a function of devel-
opment and cardiac region.
In summary, Nav from neonatal ventricles are appar-
ently less functionally sialylated than Nav from neonatal 
atria and adult atria and ventricles, and this reduced 
sialylation is responsible for much of the chamber-
  specifi  c and development-dependent differences in Nav 
gating observed here.
Differential Sialylation Modulates Nav Gating through Two 
Different Mechanisms
Previous data from our laboratory indicated that vari-
ous Nav α subunits are differently glycosylated/sialylated 
as expressed in the same cell line. This difference in 
α subunit sialylation directly and differently alters chan-
nel gating (Bennett, 2002). Thus, channel gating is par-
tially dependent on the “glycosylation signature” of the 
α subunit expressed. The number and/or location of 
  sialic acids vary among α subunits, producing a poten-
tial spectrum of functional sialic acids among α sub-
units that may directly and differently modulate channel 
gating acutely.
The data shown here are consistent with a second 
“cell-specifi  c” mechanism by which differential channel 
sialylation modulates Nav gating. We show that Nav gat-
ing throughout the developing ventricle shifts in the 
hyperpolarized direction because the adult Nav α sub-
unit is apparently more heavily sialylated than the 
α subunit from neonatal ventricles. One possible expla-
nation for this increased sialylation would be a chronic 
increase in sialyltransferase activity in the developing 
ventricles. Also, greater sialyltransferase activity in the 
newborn atria versus ventricle might explain the in-
crease in atrial α subunit functional sialylation. Consis-
tently, our recent GeneChip microarray analysis of the 
developing myocardium indicated signifi  cant develop-
mental and chamber-specifi  c differences in sialyltrans-
ferase expression (unpublished data).
Thus, as the model in Fig. 8 illustrates, we predict two 
mechanisms by which differential sialylation might alter 
Nav gating: (1) subunit specifi  c (Bennett, 2002), and 
(2) cell specifi  c (as suggested here). Each mechanism 
might produce a set of sugar-dependent gating motifs. 
The combining of the two mechanisms would increase 
the number of putative gating motifs dramatically, ef-
fectively modulating Nav function by creating a spec-
trum of Nav that gate at different voltages.
It may be inferred from the model shown in Fig. 8 
that the rate of modulation of Nav gating through 
subunit- and cell-specifi  c differential sialylation would 
be limited by the rate of protein synthesis. That is, 
expression of a specifi   c channel and the specifi  c 
sialyltransferases active in the Golgi as that channel is 
traffi  cked through the Golgi together will determine 
the level/location of functional channel sialylation. 
However, there is evidence that for other cell types, 
such modulation may take place on a more dynamic 
time scale. For example, internalized surface proteins 
might reenter directly into the Golgi glycosylation path-
way (Snider and Rogers, 1986; Brandli and Simons, 
1989; Jin and Snider, 1993). If this occurs in cardiomyo-
cytes, then a differently sialylated channel might be pro-
duced through a process that would be faster than one 
requiring de novo protein synthesis. Also, more rapid 
differential sialylation might be achieved through ecto-
sialyltransferase activity. Ecto-sialyltransferases were 
shown to be responsible for changes in transmembrane 
protein surface sialylation in certain cell types (Taatjes 
et al., 1988; Gross et al., 1996; Kaufmann et al., 1999; 
Schwartz-Albiez et al., 2004). If such a mechanism is in-
volved in cardiomyocytes, then these ecto-sialyltransferases 
might produce rapid adjustments to surface channel 
  sialylation. Thus, if these two mechanisms are involved 
in cardiac physiology, the rate of modulation of Nav gat-
ing imposed through differential channel sialylation 
might occur across a spectrum of rates, ranging from 
relatively rapid differential ecto-sialyltransferase activity 
to the much slower rate of protein synthesis.
Developmental Effects of Differential Sialylation 
May Be Tissue Speciﬁ  c
Differential sialylation appears to be a mechanism by 
which cardiac Nav activity can be modulated through-
out development or between cardiac chambers. We ob-
served essentially uniform hyperpolarizing shifts in each 
Nav gating parameter with development of the ventricle 
that was linked to increasing channel sialylation. 
A recent study of Nav1.9 in rat dorsal root ganglia also 
  reported developmental regulation of channel si-
alylation. The apparently more heavily sialylated neona-
tal Nav1.9 inactivated at more hyperpolarized potentials 
than did the adult Nav1.9. Channel activation voltage was 
unaffected (Tyrrell et al., 2001). Interestingly, these 
  opposing changes in dorsal root ganglion Nav1.9 and 
TABLE II
Gel Shift Analyses for Nav from Neonatal and Adult Cardiomyocytes 
under Conditions of Full and Reduced Glycosylation/Sialylation
Myocyte type Untreated (n) PNGase-F (n) Neuraminidase (n)
Neonatal ventricle 246.5 ± 0.8 (19) 231.6 ± 1.9 (6)a 241.2 ± 0.7 (13)a
Adult ventricle 251.8 ± 1.2 (18)a 231.3 ± 2.0 (6)a 242.0 ± 1.1 (12)a
Neonatal atria 252.2 ± 0.5 (12)a 230.2 ± 1.1 (4)a 243.1 ± 0.6 (8)a
Adult atria 251.4 ± 0.4 (11)a 230.7 ± 1.2 (4)a 243.3 ± 0.5 (7)a
Data list the mean apparent molecular weight (Mr; in kD) ± SEM measured 
for neonatal and adult cardiomyocyte Nav  α subunits. The number 
of samples, n, for each is listed in parentheses. For the untreated data, 
signifi  cance was determined using a two-tailed Student’s t test comparing 
the α subunit Mr from neonatal atria and adult atria and ventricles to the 
α subunit Mr from neonatal ventricles. The same test for signifi  cance was 
used comparing treated homogenates to untreated controls.
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  cardiac Nav sialylation throughout the development of 
two different cell types suggest that channel gating is 
modulated chronically through tissue-specifi  c differen-
tial sialylation. In addition, these uniform gating shifts 
for differentially sialylated cardiac Nav versus the non-
uniform shifts (only Vi was affected) for Nav1.9 suggest 
that the modulation of Nav gating through cell-specifi  c 
differential sialylation may be isoform specifi  c.
Differential Sialylation Modulates the Rate of Recovery 
from Fast Inactivation and the Window Current, 
thereby Likely Impacting Cardiac Excitability
Here we show that Nav gating is altered by the addition 
of functional sialic acids to channels throughout devel-
opment of the ventricle. In addition, Nav from neonatal 
atria have a greater level of functional sialic acids than 
do Nav from neonatal ventricles. What might be the 
physiological role for such developmental and  chamber-
specifi   c remodeling? The changes in Nav gating ob-
served here, such as shifts in the window current voltage 
range and changes in the rate of recovery from inactiva-
tion, previously were implicated in causing increased 
susceptibility to arrhythmias and/or reentrant excita-
tion that lead to several cardiac disorders including 
LQTS (Abriel et al., 2001; Nuyens et al., 2001), IVF 
(Chen et al., 1998), and heart failure (Ufret-Vincenty 
et al., 2001a).
The distribution of channels between the open and 
inactivated states at a membrane potential represented 
graphically by overlapping G-V and hinf curves is re-
ferred to as the “window current” (Attwell et al., 1979). 
The intersecting area under the curves represents the 
voltage range at which a small percentage of channels 
are persistently active. For the Nav from neonatal atria 
and adult atria and ventricles, the window current volt-
age range is  10 mV more hyperpolarized than is the 
window current voltage range for the Nav from neonatal 
ventricles, caused primarily by SA-dependent hyperpo-
larizing shifts in the G-V and hinf curves (Fig. 1, A and B). 
Once desialylated/deglycosylated, the window current 
voltage ranges for Nav from neonatal atria and adult 
atria and ventricles were shifted in the depolarized di-
rection, to similar voltage ranges as that observed for 
channels from neonatal ventricles (Figs. 2, 3, and 6). 
Previous reports suggest that point mutations of SCN1A 
and SCN5A resulting in similar shifts in the window cur-
rent voltage range as observed here with desialylation/
deglycosylation may be responsible for such maladies as 
epilepsy and arrhythmias (LQTS) (Abriel et al., 2001; 
Spampanato et al., 2004).
Figure 8.  Is Nav gating modu-
lated through two complemen-
tary mechanisms of differential 
sialylation? Model depicts sub-
unit- and cell-specifi  c differential 
sialylation. Each mechanism po-
tentially can produce a modest 
spectrum of channel gating motifs 
(shown for illustrative purposes 
only, as different G-V relation-
ships). Top left panel, subunit-
specifi  c differential sialylation. 
Each α subunit will have an in-
herent “glycosylation signature” 
that predetermines the level/ 
location of glycosylation that can 
be attached to that α subunit. 
Top right panel, cell-specifi  c 
differential sialylation. The rela-
tive activity of one to several of 
the 20 STs will determine the 
amount and location of sialic 
acids added to one α subunit. 
When combined together (bot-
tom), perhaps hundreds of gat-
ing motifs could be realized. For 
example, by assuming that each 
of the 10 Nav α subunits might 
be sialylated differently by the 
activity of each of the 20 known 
STs, 200 different gating motifs 
might be possible. This model is likely oversimplifi  ed, as it does not account for the even greater number of gating motifs that might 
be realized through activity of multiple STs in various combinations, or for the varied expression/activity of other glycosylation-related 
genes. Thus, with the regulated expression of specifi  c α subunits combined with the regulated expression and activity of specifi  c STs, Nav 
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While our data indicate an SA-dependent shift in 
window current voltage range that apparently impacts 
persistent Na+ channel activity, we also observe a remar-
kable SA-dependent slowing of the rate of   recovery 
from fast inactivation for all but the channels from 
neonatal ventricles. That is, as shown in Figs. 5 and 6, 
Nav from neonatal atria and adult atria and ventricles 
recover from fast inactivation more slowly than do 
channels from neonatal ventricles. This SA-dependent 
slower recovery rate will act to increase the effective 
time between successive depolarizing/repolarizing 
waves because of the redistribution of Nav toward a 
larger population of inactivated channels. Previous re-
ports have suggested that faster recovery rates increase 
the probability of reentrant excitation or early afterde-
polarizations, possibly resulting in LQT-3 (Nuyens et al., 
2001) or in IVF (Chen et al., 1998). In fact, Chen et al. 
(1998) suggested that SCN5A mutations that were re-
sponsible for a 25–30% faster recovery rate at a −80 mV 
recovery potential might cause IVF. The authors 
showed that this difference in recovery rate between 
wild type and the mutant SCN5A attenuated with 
more hyperpolarized recovery potentials, becoming 
insignifi  cant at recovery potentials more negative than 
−110 mV. Here we report a much larger SA-  dependent 
effect on recovery rate. At a −120 mV recovery poten-
tial, the rate of recovery from inactivation for the less 
sialylated Nav from neonatal ventricles is 40–60% faster 
than for the more heavily sialylated channels from 
neonatal atria and adult atria and ventricles (Table I). 
Thus, our data indicate that the differential sialylation 
of Nav throughout the developing myocardium may 
have a greater impact on the rate of recovery from 
fast inactivation than do SCN5A mutation(s) that 
lead to IVF.
A recent study suggested a role for sialic acids in car-
diomyocyte excitability (Ufret-Vincenty et al., 2001a). 
Cardiac excitability and Nav gating were studied using a 
mouse model for heart failure, a knockout of the mus-
cle LIM protein (MLP). Neuraminidase treatment of 
control (wild type) ventricular myocytes produced Na+ 
currents with steady-state gating characteristics similar 
to those of untreated, but apparently less sialylated, 
MLP−/− myocytes. This suggested that the extended ac-
tion potential repolarization of the MLP−/− myocyte 
was caused, at least in part, by Nav with reduced 
sialylation. There was a reduction and rightward shift in 
the window current of the Nav from MLP−/− myocytes 
and also for Nav from the neuraminidase-treated   control 
myocytes. In addition, the rate of fast inactivation was 
slowed for Nav from desialylated and MLP−/− myocytes. 
The action potential duration in MLP−/− myocytes 
was prolonged, and these myocytes were more suscepti-
ble to early afterdepolarizations. The authors concluded 
that the apparently lesser sialylated Nav from MLP−/− 
myocytes might be responsible for these changes in 
myocyte excitability. Interestingly, both the rightward 
shift in window current voltage range and the slower 
  inactivation rates described for Nav from MLP−/− 
  myocytes are consistent with that observed here for all 
desialylated channels and for treated and untreated 
channels from neonatal ventricles.
Thus, the probable net role for Nav differential si-
alylation is to help regulate and modulate cardiac 
rhythms achieved through SA-dependent shifts in Nav 
window current and/or SA-dependent changes in the 
rate of recovery from inactivation.
Summary
Here we show a developmental and chamber-specifi  c 
role for cell-specifi  c differential sialylation in cardio-
myocyte ion channel function. Functional analyses of 
cardiomyocyte Nav showed that Nav from neonatal 
atria and adult atria and ventricles gate at more hyper-
polarized potentials than do channels from neonatal 
ventricles. Much of these region-specifi  c and develop-
mental shifts in gating were shown to be sialic acid 
  dependent, with complete removal of N-glycosylation 
accounting fully for these shifts. This developmental 
and chamber-specifi  c differential sialylation modulates 
the rate of Nav recovery from fast inactivation to a 
greater extent than does an SCN5A mutation impli-
cated as causal for IVF, further indicating the potential 
importance of differential Nav sialylation to cardiac 
excitability. A complete description of the role of dif-
ferential sialylation in cardiac excitability throughout 
the developing myocardium must wait until further 
investigation determines the effects of differential 
  sialylation on the other ion channels and transporters 
involved in the varied action potentials observed 
throughout the developing myocardium.
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